<DOC>
	<DOCNO>NCT03105934</DOCNO>
	<brief_summary>To assess correlation pulmonary IV-OCT pulmonary IV-US measurement standard PAH clinical measure disease progression relative sensitivity technique change .</brief_summary>
	<brief_title>Repeatability OCT IV-US Pulmonary Arterial Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<criteria>With confirm diagnosis PAH Group 1 accord ESC/ERS Guidelines With severe disease , define Class II III modify WHO functional class ESC/ERS Guidelines That accord investigator criterion participate trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>